HomeCompareBCTXW vs DGRO

BCTXW vs DGRO: Dividend Comparison 2026

BCTXW yields 222222.22% · DGRO yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCTXW wins by $1.4076449094288678e+30M in total portfolio value
10 years
BCTXW
BCTXW
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076449094288678e+30M
Annual income
$1,406,399,938,745,922,600,000,000,000,000,000,000.00
Full BCTXW calculator →
DGRO
iShares Core Dividend Growth ETF
● Live price
2.13%
Share price
$68.98
Annual div
$1.47
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$239.96
Full DGRO calculator →

Portfolio growth — BCTXW vs DGRO

📍 BCTXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCTXWDGRO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCTXW + DGRO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCTXW pays
DGRO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCTXW
Annual income on $10K today (after 15% tax)
$18,888,889.10/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,947,934,034,100,000,000,000,000,000,000.00/yr
DGRO
Annual income on $10K today (after 15% tax)
$181.24/yr
After 10yr DRIP, annual income (after tax)
$203.97/yr
At 15% tax rate, BCTXW beats the other by $1,195,439,947,934,034,100,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCTXW + DGRO for your $10,000?

BCTXW: 50%DGRO: 50%
100% DGRO50/50100% BCTXW
Portfolio after 10yr
$7.038224547144339e+29M
Annual income
$703,199,969,372,961,300,000,000,000,000,000,000.00/yr
Blended yield
99.91%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCTXW buys
0
DGRO buys
0
No recent congressional trades found for BCTXW or DGRO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCTXWDGRO
Forward yield222222.22%2.13%
Annual dividend / share$2.00$1.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.4076449094288678e+30M$31.6K
Annual income after 10y$1,406,399,938,745,922,600,000,000,000,000,000,000.00$239.96
Total dividends collected$1.4075633997820162e+30M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BCTXW vs DGRO ($10,000, DRIP)

YearBCTXW PortfolioBCTXW Income/yrDGRO PortfolioDGRO Income/yrGap
1← crossover$22,232,922$22,222,222.47$11,293$213.22+$22.22MBCTXW
2$46,198,083,549$46,174,294,322.26$12,730$217.32+$46198.07MBCTXW
3$89,718,755,932,306$89,669,323,982,908.17$14,326$221.10+$89718755.92MBCTXW
4$162,845,400,843,462,850$162,749,401,774,615,260.00$16,098$224.56+$162845400843.45MBCTXW
5$276,249,751,218,492,180,000$276,075,506,639,589,670,000.00$18,064$227.74+$276249751218492.16MBCTXW
6$437,989,491,440,595,100,000,000$437,693,904,206,791,440,000,000.00$20,246$230.65+$437989491440595136.00MBCTXW
7$649,026,193,150,457,500,000,000,000$648,557,544,394,616,000,000,000,000.00$22,666$233.30+$649026193150457544704.00MBCTXW
8$898,874,233,030,415,400,000,000,000,000$898,179,775,003,744,500,000,000,000,000.00$25,349$235.73+$8.988742330304155e+23MBCTXW
9$1,163,524,002,752,517,800,000,000,000,000,000$1,162,562,207,323,175,100,000,000,000,000,000.00$28,325$237.94+$1.1635240027525178e+27MBCTXW
10$1,407,644,909,428,867,700,000,000,000,000,000,000$1,406,399,938,745,922,600,000,000,000,000,000,000.00$31,624$239.96+$1.4076449094288678e+30MBCTXW

BCTXW vs DGRO: Complete Analysis 2026

BCTXWStock

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Full BCTXW Calculator →

DGROETF

The iShares Core Dividend Growth ETF seeks to track the investment results of an index composed of U.S. equities with a history of consistently growing dividends.

Full DGRO Calculator →
📬

Get this BCTXW vs DGRO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCTXW vs SCHDBCTXW vs JEPIBCTXW vs OBCTXW vs KOBCTXW vs MAINBCTXW vs VIGBCTXW vs NOBLBCTXW vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.